Literature DB >> 23212674

Expression of the immunoreactive buckwheat major allergenic storage protein in Lactococcus lactis.

Suguru Shigemori1, Shinichi Yonekura, Takashi Sato, Hajime Otani, Takeshi Shimosato.   

Abstract

Proteins from buckwheat (Fagopyrum esculentum) are strong allergens that can cause serious symptoms, including anaphylaxis, in patients with hypersensitivity. In this study, we successfully developed a modified lactic acid bacterial vector (pNSH) and a recombinant strain of Lactococcus lactis NZ9000 (NZ9000) that produced a major allergenic storage protein of buckwheat, Fagag1 (61.2 kDa, GenBank accession number AF152003), with or without a green fluorescent protein (GFP) tag. GFP fluorescence allows for rapid, simple, and accurate measurement of target protein expression by microscopy or fluorimetry. We describe a convenient method for production of rGFP-Fagag1 fusion and rFagag1 proteins with a good yield in an advantageous probiotic host. We found that in vitro treatment of splenocytes isolated from buckwheat crude protein-immunized mice with rFagag1 increased the expression of allergic inflammation cytokines such as IL-4, IL-13, and IL-17 F. Because it was less antigenic, rGFP-Fagag1 protein from NZ9000 might be of limited use; however, rFagag1 from NZ9000 evoked a robust response as measured by induction of IL-4 and IL-17 F expression levels. The observed allergic activity is indicative of a Th2 cell-mediated immune response and is similar to the effects induced by exposure to buckwheat crude protein. Our results suggest that expression of rFagag1 in NZ9000 may facilitate in vivo applications of this system aimed at improving the specificity of immunological responses to buckwheat allergens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212674     DOI: 10.1007/s00253-012-4608-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  6 in total

1.  Inhibitory/suppressive oligodeoxynucleotide nanocapsules as simple oral delivery devices for preventing atopic dermatitis in mice.

Authors:  Yeqin Wang; Yoshinari Yamamoto; Suguru Shigemori; Takafumi Watanabe; Kazushi Oshiro; Xinyu Wang; Pengfei Wang; Takashi Sato; Shinichi Yonekura; Sachi Tanaka; Haruki Kitazawa; Takeshi Shimosato
Journal:  Mol Ther       Date:  2014-12-15       Impact factor: 11.454

2.  Generation of dipeptidyl peptidase-IV-inhibiting peptides from β-lactoglobulin secreted by Lactococcus lactis.

Authors:  Suguru Shigemori; Kazushi Oshiro; Pengfei Wang; Yoshinari Yamamoto; Yeqin Wang; Takashi Sato; Yutaka Uyeno; Takeshi Shimosato
Journal:  Biomed Res Int       Date:  2014-08-03       Impact factor: 3.411

Review 3.  Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case.

Authors:  Sofie Robert; Lothar Steidler
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

4.  Concomitant sensitization to legumin, Fag e 2 and Fag e 5 predicts buckwheat allergy.

Authors:  S Geiselhart; C Nagl; P Dubiela; A C Pedersen; M Bublin; C Radauer; C Bindslev-Jensen; K Hoffmann-Sommergruber; C G Mortz
Journal:  Clin Exp Allergy       Date:  2017-12-22       Impact factor: 5.018

5.  Large scale text mining for deriving useful insights: A case study focused on microbiome.

Authors:  Syed Ashif Jardary Al Ahmed; Nishad Bapatdhar; Bipin Pradeep Kumar; Samik Ghosh; Ayako Yachie; Sucheendra K Palaniappan
Journal:  Front Physiol       Date:  2022-08-31       Impact factor: 4.755

6.  Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.

Authors:  Suguru Shigemori; Takafumi Watanabe; Kai Kudoh; Masaki Ihara; Shireen Nigar; Yoshinari Yamamoto; Yoshihito Suda; Takashi Sato; Haruki Kitazawa; Takeshi Shimosato
Journal:  Microb Cell Fact       Date:  2015-11-25       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.